Detalhe da pesquisa
1.
Comparison of methods for delivering a lifestyle modification program for obese patients: a randomized trial.
Ann Intern Med
; 150(4): 255-62, 2009 Feb 17.
Artigo
Inglês
| MEDLINE | ID: mdl-19221377
2.
Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism.
J Lipid Res
; 50(7): 1456-62, 2009 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-19193611
3.
Health-risk appraisal with or without disease management for worksite cardiovascular risk reduction.
J Cardiovasc Nurs
; 23(6): 513-8, 2008.
Artigo
Inglês
| MEDLINE | ID: mdl-18953215
4.
Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol.
N Engl J Med
; 350(15): 1505-15, 2004 Apr 08.
Artigo
Inglês
| MEDLINE | ID: mdl-15071125
5.
Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
Arterioscler Thromb Vasc Biol
; 26(6): 1350-6, 2006 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-16574893
6.
Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.
Arterioscler Thromb Vasc Biol
; 25(5): 1057-64, 2005 May.
Artigo
Inglês
| MEDLINE | ID: mdl-15761191
7.
Evaluation of methods for improving precision of blood pressure measurements in phase I clinical trials.
J Clin Pharmacol
; 44(5): 457-63, 2004 May.
Artigo
Inglês
| MEDLINE | ID: mdl-15102865
8.
Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism.
J Lipid Res
; 49(3): 543-9, 2008 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-18033754